Hospital or health organisation · founded 1904
Fox Chase Cancer Center
Philadelphia, United States · foxchase.org
Part of Temple University Health System
- Citations, last 5 years
- 62.9k
- Works, last 5 years
- 4 126
- h-index
- 738
- Scientists listed
- 0
- Grants since 2016
- 606
Grants received
2022–2027 · research · R00
Positive Activities for Asian American Cancer Patients and Caregivers
Lilian J Shin-Cho · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · UH3
Validation of blood-based predictive biomarkers of therapeutic response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
Sanjeevani Arora · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
Edna Cukierman · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Administrative Core
Margie L. Clapper · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
Edna Cukierman · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Refolding Mutant p53: A Strategy for Cancer Prevention in Li-Fraumeni Syndrome
Erica A. Golemis · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Informatics Core
Eric Andrew Ross · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Administrative Core
Margie L. Clapper · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Informatics Core
Eric Andrew Ross · Fox Chase Cancer Center · funded by National Institutes of Health
2022–2027 · cooperative agreement · U54
Refolding Mutant p53: A Strategy for Cancer Prevention in Li-Fraumeni Syndrome
John Karanicolas · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2023 · research · R21
Building clinically faithful ex vivo indolent lymphoma models for personalized therapy
Y. Lynn Wang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients
Philip Abbosh · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2024 · research · R21
Building clinically faithful ex vivo indolent lymphoma models for personalized therapy
Y. Lynn Wang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2023 · research · R21
Neurotransmitter signaling controls stem cell fate
Alana M O'Reilly · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients
Philip Abbosh · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2022 · award
Evaluation of a PAK1-selective PROTAC, alone and with Hippo inhibitors, as a targeted therapy in NF2
Jonathan Chernoff · Fox Chase Cancer Center · funded by Children's Tumor Foundation
2021–2026 · research · R01
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2024 · research · R21
Neoadjuvant Stroma Modification in Pancreatic Cancer
Igor Astsaturov · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients
Philip Abbosh · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2023 · research · R21
Neoadjuvant Stroma Modification in Pancreatic Cancer
Igor Astsaturov · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2024 · research · R21
Neurotransmitter signaling controls stem cell fate
Alana M O'Reilly · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients
Philip Abbosh · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2026 · research · R01
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2023 · research · R56
Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2021 · career development · Young Investigator Award
Genotyping of BRCA1 mutations predicts radiosensitivity in breast cancers and in cultured breast cancer cells
Rebecca Shulman · Fox Chase Cancer Center · funded by Conquer Cancer Foundation
2021–2027 · cooperative agreement · U01
Optimization of urinary DNA deep sequencing tests to enhance clinical staging of bladder cancer patients
Philip Abbosh · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2027 · research · R01
Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2021–2027 · research · R01
Analysis and Therapeutic Targeting of the Linear-Ubiquitination Pathway in Hodgkin Lymphoma
Yibin Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2023 · research · R21
Characterization of New Allosteric Inhibitors that Disrupt HIV-1 Integrase Dimerization
Mark David Andrake · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2021 · research · R13
ThymUS 2020 International Conference on Lymphopoiesis
David L. Wiest · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2025 · research · R01
MTAP, 5'-deoxy-5'-methylthioadenosine, and the dysregulation of symmetric dimethylarginine in cancer
Warren D Kruger · Fox Chase Cancer Center · funded by National Institutes of Health
2020–2024 · research · R01
Dissecting BRCA1-PALB2 Activity in DNA Repair and Development
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health